New Bioactive Compounds Target Focal Adhesion Kinase 2
In a groundbreaking advance in cancer therapy, researchers have unveiled innovative findings identifying Cucurbitacin S and Kammogenin as potent inhibitors ...
In a groundbreaking advance in cancer therapy, researchers have unveiled innovative findings identifying Cucurbitacin S and Kammogenin as potent inhibitors ...
In a groundbreaking study published in Reproductive Sciences, researchers Liu and Zhao unveil significant insights into the genetic underpinnings of ...
Every year, more than 300,000 women worldwide receive the devastating diagnosis of ovarian cancer, a disease notorious for its complexity ...
In an ambitious stride towards precision oncology, the American College of Medical Genetics and Genomics (ACMG) has unveiled a groundbreaking ...
In a groundbreaking study poised to reshape therapeutic strategies for early-stage HER2-positive breast cancer, researchers have delved deep into the ...
At the recent European Society for Medical Oncology (ESMO) Congress 2025 held in Berlin, researchers from Memorial Sloan Kettering Cancer ...
In recent years, the role of ANXA2 (Annexin A2) in hepatocellular carcinoma (HCC) has attracted significant attention from researchers and ...
In the quest to unlock the mysteries of pancreatic cancer, researchers have increasingly turned their attention to the role of ...
In the evolving landscape of oncology, the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) remains a crucial challenge. Understanding the mechanisms ...
In an innovative breakthrough study published in BMC Cancer, researchers have unveiled that systemic inflammation biomarkers may hold the key ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine